Home > News
Search  
Research
   Research Overview
   Research Divisions
   Research Faculty

Patient Information
   Clinical Research
   Clinical Trials
   Faculty

Research Resources
   Technology Transfer
   Research Services

Education / Outreach

News
Media Releases
TGen Podcasts
TGen Newsfeed (RSS)
Receive Email News

Help Support TGen

About TGen

Contact

TGen North

TGen Drug Development Services (TD2)

Van Andel Research Institute




Galen Perry
602.343.8423
gperry@tgen.org

Steve Yozwiak
602.343.8704
syozwiak@tgen.org

Media Releases

TGen finds therapeutic targets for rare cancer in children
RNAi screening used for the first time to study Ewing’s sarcoma
August 31 2010
The first study of Ewing’s sarcoma that screened hundreds of genes based on how they affect cell growth has identified two potential anti-cancer drug targets...

TGen’s new link to ASU supercomputer is nation’s fastest
Cox Business LightWave Service connection, enhanced by Obsidian Strategics military technology, accelerates analysis of disease research
August 13 2010
A new light-speed computer connection using a military-tested network provides TGen with the nation’s fastest supercomputer link...

International executive will swim English Channel in memory of his son
New Jersey businessman supports TGen’s research into bipolar disorder
August 2 2010
In memory of his son, a 59-year-old New Jersey businessman plans this week to support bipolar disorder research at TGen...

TGen provides scientific springboard for Helios Scholars
Eight weeks of summer instruction readies students for scientific careers
July 30 2010
Tomorrow’s leaders in science and medicine graduated today from one of the nation’s most advanced summer internship programs at TGen...

TGen Alzheimer’s researcher bikes 200 miles to help increase funding
Dr. Matthew Huentelman conducts Arizona leg of ‘Breakthrough Ride’
July 29 2010
TGen's Dr. Matthew Huentelman will trade test tubes and his lab coat today for a safety helmet and shorts as he bikes 200 miles to help increase funding...

TGen affiliate, Van Andel Research Institute, joins with Spectrum Health and oncology group to develop Phase I clinical trial program
Alliance brings West Michigan patients the latest in experimental research
July 27 2010
An affiliate of TGen will provide cancer patients in West Michigan opportunities to access new drugs to fight their disease...

The Marilyn B. Gula Mountains of Hope Foundation donates additional research funds to TGen and University Hospitals Ireland Cancer Center
100 percent of donations support advanced breast cancer research and treatment
July 26 2010
The Marilyn B. Gula Mountains of Hope Foundation continues its fight against advanced breast cancer with a $50,000 donation to TGen...

TGen finds protein inhibitor revives chemotherapy for ovarian patients
Discovery provides new hope to cancer patients with few treatment options
July 8 2010
Investigators at the Translational Genomics Research Institute (TGen) have discovered a way that may help ovarian cancer patients

New TGen technology reduces storage needs and costs for genomic data
G-SQZ provides scientists with compact format for genomic data processing
July 6 2010
A new computer data compression technique called Genomic SQueeZ...

Arizona Myeloma Network presents ‘Special Award’ to TGen president
AzMN recognizes TGen’s help in ‘All Cancers’ run and Navajo conference
July 1 2010
The Arizona Myeloma Network (AzMN) has presented a “Special Award” to Dr. Jeffrey Trent...

[more] 11 of 246 >>

E-MAIL THIS ARTICLE

PRINT THIS PAGE

SIGN-UP FOR NEWS



Follow us on Twitter
    Podcasts
    NewsFeed

       Home | About TGen | Research | Clinical Research | Research Services | Education/Outreach

    News | Help Support TGen | Contact | Careers
     

    Copyright 2009, The Translational Genomics Research Institute (TGen)
    445 N. Fifth Street, Phoenix, AZ 85004
    phone 602.343.8400 toll free 1.800.642.4432